@Original Author: Dailyly
Daily update of news from around the world
#《柳叶刀》首发中药多中心双盲研究：中风醒脑液对急性脑出血疗效为零#
国际顶级医学期刊《柳叶刀》发表了由 复旦大学 教授团队和 广东省中医院 教授团队 共同完成的一项研究，该研究旨在评估 中药 中风醒脑方 对急性脑出血患者的疗效和安全性，这项研究是中国首个在《柳叶刀》上发表的中药多中心双盲临床试验，共纳入1600多名患者，涉及中国26家医院。
研究结果：该药物对患者无任何治疗效果。
中风醒脑液是源于 国医大师 陈绍宏教授验方制成的中药复方制剂，临床用于急性脑出血超过20年。
#The Lancet published the first multi-center double-blind study of traditional Chinese medicine: The efficacy of Zhongfeng Xingnaoye on acute cerebral hemorrhage is zero#
The top international medical journal The Lancet published a study jointly completed by a team of professors from Fudan University and Guangdong Provincial Hospital of Traditional Chinese Medicine. The study aims to evaluate the efficacy and safety of the traditional Chinese medicine Zhongfeng Xingnaoye on patients with acute cerebral hemorrhage. This study is the first multi-center double-blind clinical trial of traditional Chinese medicine published in The Lancet in China. More than 1,600 patients were included in 26 hospitals in China.
Research results: The drug has no therapeutic effect on patients.
Zhongfeng Xingnaoye is a traditional Chinese medicine compound preparation made from the prescription of Professor Chen Shaohong, a master of traditional Chinese medicine, and has been clinically used for acute cerebral hemorrhage for more than 20 years.